5 SIMPLE STATEMENTS ABOUT AZ-23 EXPLAINED

quinupristin/dalfopristin raises levels of erythromycin lactobionate by reducing metabolism. Contraindicated. Hazard of extended QTc interval.quinupristin/dalfopristin will improve the degree or outcome of sunitinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.quinupristin/dalfopristin will reduce the level or outco